Medium Risk

HESTER BIOSCIENCES LIMITED

Manufacturing and trading of veterinary vaccines and health products

CIN: L99999GJ1987PLC022333 FY: - Revenue: ₹286.5 Cr
5.4
ESG Risk
Score /10
Compliance RiskEpr ExposureGhg Intensity

Risk Breakdown

GHG Intensity
5.0
Water Intensity
5.0
Waste Intensity
1.2
EPR Exposure
6.5
Compliance Risk
10.0
HR Risk
3.0
Governance Risk
5.0

Financial Exposure

Est. Compliance Cost₹0–2 crore
EPR ApplicableUnknown
Scope 1 Emissions— tCO2e
Scope 2 Emissions— tCO2e
Water Withdrawal— m³
Waste Generated716.3 T

Governance

Anti-Corruption PolicyYes
Conflict of Interest PolicyUnknown
BRSR AssuranceNone
Assurance Provider

Double Materiality

Financial Materiality5.4
Impact Materiality4.6
QuadrantFinancially Material

Supply Chain

MSME Sourcing0.5%
Lifecycle AssessmentNo
Product ReclaimYes

Material Risks

e-waste

ESG Targets & Commitments

TopicTarget / MetricStatus
Human Rights in Supply Chain HR clauses in all contracts Commitment

AI Risk Summary

**Financial Risk Summary: Hester Biosciences Limited** Hester Biosciences faces critical compliance risk (10.0/10 score) as a BRSR-mandated entity with incomplete emissions reporting (zero Scope 1 and 2 data suggests non-disclosure rather than absence), exposing it to SEBI enforcement action and potential delisting under BRSR Core Expansion requirements. Extended Producer Responsibility (EPR) liability represents the largest unquantified financial exposure at 6.5/10 risk intensity, particularly acute given unknown EPR applicability status—veterinary vaccine packaging waste obligations could trigger ₹2–8 crore in remediation costs if compliance gaps are discovered. The estimated compliance cost range of ₹0–2 crore appears significantly understated given the high compliance risk rating and EPR uncertainty; additional capex for environmental management systems, emissions verification, and EPR infrastructure could realistically reach ₹3–5 crore annually once full regulatory obligations are clarified.

Source: HESTER BIOSCIENCES LIMITED BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.

← Back to ESG Quotient Dashboard Share on LinkedIn Browse all companies →